inVentiv Health, a leading provider of end-to-end clinical development, launch and commercialization services to the global healthcare industry, announced today that it has acquired Substrat'Homme SA, commonly known as Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. As part of the inVentiv Communications Global Alliance, Star Terre Santé will provide advertising and promotional services to inVentiv Communications' clients in France and Benelux.
inVentiv Communications, a division of inVentiv Health, and Star Terre Santé have partnered since 2009 to serve the marketing and advertising needs of clients in France, the third-largest pharmaceutical market in the world. Through the transaction, Star Terre Santé will become a wholly owned subsidiary of inVentiv. Financial terms were not disclosed.
Star Terre Santé is comprised of seven healthcare-focused communications disciplines, including Terre Neuve, a leading advertising agency with clients such as Guerbet, Merck Serono, Lilly and Johnson & Johnson.
"Star Terre Santé has built an exceptionally strong reputation for delivering successful communications and marketing solutions to healthcare clients in France and Benelux," said Phil Deschamps, Chief Global Officer of inVentiv Communications. "We are thrilled to formalize our relationship with them and we look forward to continuing to work together to serve our growing base of clients that are marketing products in Europe."
"As we considered the opportunity to expand our business, we wanted to partner with a communications network that brought deep experience and a broad range of resources," said Stéphane Laford, President of Star Terre Santé. "inVentiv's unique focus in healthcare and their breadth of service offerings for pharmaceutical and biotech clients makes them an ideal partner for us."
New study aims to reduce bias in AI health prediction models